The Nevada Department of Health and Human Services this week sent penalty letters to 21 drug manufacturers of certain diabetes drugs, seeking $17.4 million in penalties for non-compliance with a new price transparency law.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,